ProCE Banner Activity

Biomarker-Driven Treatment of GI Cancers

Slideset Download
Download this slideset for expert medical oncologist and pathologist perspectives on current best practices in biomarker testing and leveraging testing results to inform treatment strategies for patients with gastrointestinal cancers.

Released: August 05, 2021

Expiration: August 04, 2022

No longer available for credit.

Share

Faculty

Allison M. Cushman-Vokoun

Allison M. Cushman-Vokoun, MD, PhD

Associate Professor
Department of Pathology and Microbiology
University of Nebraska Medical Center
Medical Director
Molecular Diagnostics Laboratory and Human Genetics Laboratory
Department of Pathology and Microbiology
Nebraska Medicine
Omaha, Nebraska

John L. Marshall

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Allison M. Cushman-Vokoun, MD, PhD

Associate Professor
Department of Pathology and Microbiology
University of Nebraska Medical Center
Medical Director
Molecular Diagnostics Laboratory and Human Genetics Laboratory
Department of Pathology and Microbiology
Nebraska Medicine
Omaha, Nebraska

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC